- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ConvaTec Group PLC (CTEC)
The ConvaTec Group share price today is 221.00 %REPORT_CURRENCY%, view LON CTEC stock exchange data. Track the latest ConvaTec Group share price with real-time updates on CTEC stock performance including market cap, day range, 52-week range and dividend yield. Access CTEC charts, earnings dates and analyst estimates to support your investment decisions.
221.00
-3.60(-1.60%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
215.60
223.40
52 wk Range
209.40
311.20
CTEC is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
215.60223.40
52 wk Range
209.40311.20
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.32%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.32%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
CTEC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
305.27
Upside
+38.13%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, neurological disease, prostate enlargement or other causes. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for use in continuous infusion treatments for conditions such as Parkinson’s disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. Convatec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
ConvaTec Group PLC Earnings Call Summary for H2/2025
- ConvaTec achieved 6.4% organic revenue growth for 2025, marking fifth consecutive year of growth with operating margin expanding 110 bps to 22.3%
- EPS increased 16% year-over-year; stock surged 10.84% to $59.66, delivering 80% gain over past year amid strong investor confidence
- Infusion Care category led performance with 12.5% organic growth, driven by robust diabetes sector demand and expansion in other therapies
- Company faces headwinds from InnovaMatrix sales decline and FDA warning letter on complaints management requiring operational attention
- Management projects continued growth with new product launches planned for 2026-2027, focusing on high-return investments across chronic care portfolio
Last Updated: 24-02-2026, 05:26 pm
Read Full TranscriptCompare CTEC to Peers and Sector
Metrics to compare | CTEC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCTECPeersSector | |
|---|---|---|---|---|
P/E Ratio | 33.8x | 21.8x | −0.4x | |
PEG Ratio | −4.49 | 0.23 | 0.00 | |
Price/Book | 3.9x | 1.7x | 2.6x | |
Price / LTM Sales | 2.4x | 2.0x | 3.2x | |
Upside (Analyst Target) | 37.6% | 133.8% | 46.7% | |
Fair Value Upside | Unlock | 36.1% | 7.6% | Unlock |
Analyst Ratings
16 Buy
1 Hold
0 Sell
Ratings:
17 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 305.27
(+38.13% Upside)
Earnings
Latest Release
24-02-2026
EPS / Forecast
0.10 / 0.10
Revenue / Forecast
1.26B / 1.25B
FAQ
What Is the ConvaTec Group (CTEC) Share Price Today?
The ConvaTec Group share price today is 221.00 USD.
What is the current ConvaTec Group (CTEC) share price and day range?
As of 24-04-2026, the ConvaTec Group share price is 221.00 USD, with a previous close of 224.60 USD. The share price has ranged from 215.60 to 223.40 USD today, while the 52-week range spans from 209.40 to 311.20 USD.
What Is the ConvaTec Group Market Cap?
As of today, ConvaTec Group market cap is 4.32B.
Does ConvaTec Group Pay Dividends? What's The Current Dividend Yield?
The ConvaTec Group dividend yield is 2.32%.
What Is the ConvaTec Group (CTEC) Share Price Target?
The average 12-month share price target for ConvaTec Group is 305.27 USD, with a high estimate of 367.65250908 USD and a low estimate of 253.94707583 USD. 16 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +38.13% Upside potential.
What Is ConvaTec Group's Earnings Per Share (TTM)?
The ConvaTec Group EPS (TTM) is 0.09.
When Is the Next ConvaTec Group Earnings Date?
ConvaTec Group will release its next earnings report on 24-02-2026.
From a Technical Analysis Perspective, Is CTEC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does ConvaTec Group Trade On?
ConvaTec Group is listed and trades on the London Stock Exchange.
What Is the Stock Symbol for ConvaTec Group?
The stock symbol for ConvaTec Group is "CTEC."
How Many Times Has ConvaTec Group Stock Split?
ConvaTec Group has split 0 times.
How Many Employees Does ConvaTec Group Have?
ConvaTec Group has 10910 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.